A new search tool unveiled Friday increases public access to information about the connections between advisors to the ...

For example, developing a drug nowadays takes eight to ten years and costs over $2bn, yet less than 10% of clinical ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.

Shore Capital, which covers hVIVO, sees plenty of upside. The broker notes that the company’s cash generation, revenue ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

Today, there is now reliable evidence that digitally enabled trials provide value and can solve some of the most chronic ...

it could lead to the next big medical breakthrough. Yet… The biggest barrier to bringing new drugs to market isn’t discovery; it’s clinical trials. It takes hundreds of millions of dollars ...

Health tech company Flatiron Health, an independent affiliate of the Roche Group, is expanding the reach of its clinical data ...

Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.

Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...

US healthcare giant Johnson & Johnson has announced manufacturing, research and development and technology investments of ...